CCR3 is a target for age-related macular degeneration diagnosis and therapy
about
DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88AMD Genetics in India: The Missing LinksRegulation of signaling events involved in the pathophysiology of neovascular AMDGenetics of immunological and inflammatory components in age-related macular degenerationMechanisms of age-related macular degenerationAAV2 delivery of Flt23k intraceptors inhibits murine choroidal neovascularizationNanomedicine in the application of uveal melanomaLRG1 promotes angiogenesis by modulating endothelial TGF-β signalling.Study in vivo intraocular biocompatibility of in situ gelation hydrogels: poly(2-ethyl oxazoline)-block-poly(ε-caprolactone)-block-poly(2-ethyl oxazoline) copolymer, matrigel and pluronic F127Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and ApoptosisUtilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularizationCCR3 and choroidal neovascularizationThe mouse retina as an angiogenesis model.Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration.Integrative pathway-centric modeling of ventricular dysfunction after myocardial infarction.Animal models of choroidal and retinal neovascularization.Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells.Regulation of ocular angiogenesis by Notch signaling: implications in neovascular age-related macular degeneration.The Immune System and AMDHistamine H4 receptor as a new therapeutic target for choroidal neovascularization in age-related macular degenerationThe oral iron chelator deferiprone protects against iron overload-induced retinal degenerationAge-related macular degeneration: insights into inflammatory genes.Selective activation of the prostaglandin E2 circuit in chronic injury-induced pathologic angiogenesisNucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity.Milligram production and biological activity characterization of the human chemokine receptor CCR3.DICER1 deficit induces Alu RNA toxicity in age-related macular degenerationA Novel Platelet-Activating Factor Receptor Antagonist Inhibits Choroidal Neovascularization and Subretinal Fibrosis.Age-related macular degeneration and the other double helix. The Cogan Lecture.Exosomes from retinal astrocytes contain antiangiogenic components that inhibit laser-induced choroidal neovascularization.A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor.Rap1 GTPase activation and barrier enhancement in rpe inhibits choroidal neovascularization in vivo.Copy number variations in candidate genes in neovascular age-related macular degeneration.Blood expression levels of chemokine receptor CCR3 and chemokine CCL11 in age-related macular degeneration: a case-control study.Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy.Upregulation of CCR3 by age-related stresses promotes choroidal endothelial cell migration via VEGF-dependent and -independent signalingPlasma-activated medium suppresses choroidal neovascularization in mice: a new therapeutic concept for age-related macular degeneration.Suppression of Laser-Induced Choroidal Neovascularization by the Oral Medicine Targeting Histamine Receptor H4 in Mice.Increased CCL24/eotaxin-2 with postnatal ozone exposure in allergen-sensitized infant monkeys is not associated with recruitment of eosinophils to airway mucosaNovel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular Permeability.Inflammatory Mechanisms of Age-related Macular Degeneration.
P2860
0cfae2c3109081a7094280ae689de5aa88bd7b7424d565e41927c13af45097619069966b46fd87754997f78cab6f6273ade1f793a377744cb3aaaf3e4bdddc93d6923cd398fd4a244a7d1808f6d14146602ad90d22e06d897c4d6ccbc212f6db01e3b9e8738988234bf10ab1d5ebb9c2f0e83dd2401dfc6f76586c29e223b9c85f89195cdc20739230bc8cab988704096c54b4d865dcd19f9ddab953285218c0bb18daf8493facae0a4c6c8a1c2d79bab9ea6344ea82c49c9b0e9944cc2fa8b374e48156829ebba3
P248
Q24621930-35EB7914-4985-4B63-9EBE-2AC59B2C56B7Q26744092-740ED21E-867E-4CC7-A8FA-8C2CDC6ED9F7Q26751293-9FDD2CEE-EF43-41F9-B4BE-EE1DC252C2F7Q26849231-14C8B861-E429-466C-8595-F3BF05989AC2Q27000182-1A2153C8-C2B9-40CB-B4B9-3BAA89BF31F1Q27318539-FAE4907E-DF28-4D49-B21A-4AB06B495C8BQ28079572-F5A4E360-CD7C-4FC7-83A0-B34C8EE383C5Q28508560-BA88CA5A-3743-4A29-AB96-C5B0A57FEA2AQ28534435-065E3902-4F2D-465E-95D5-FC1C8BF79488Q28551885-F58F7B15-A421-4CD0-B2CA-B5C076534DA7Q28740612-3E275E46-3988-49C1-BA4D-F4CC9D1F9D09Q28742748-2CDE1EFD-D815-4418-9C46-2156E52890E0Q30495106-69DF9CB9-48D8-43EB-B11C-688530509328Q30539153-2B90F3A1-4C41-46D5-B345-7F3D6F654C18Q33543006-95A4682A-482C-4C03-A6C8-3930A7F31C5EQ33582933-6CB08362-DD72-4FA4-9E61-DB7304183AAAQ33728338-D6133E32-CF70-4413-9028-C75A0E485DCEQ33791749-14BB9F00-F468-411D-B4B1-FE7A36E57F86Q34003743-9CAC0B06-1004-437E-A33A-3D48D9BA2E84Q34025192-119F0B16-F780-4E1B-BB12-1B9D63467956Q34281402-BBF562DA-5387-4AA3-914F-8F1C26445C2FQ34588628-9451C888-9F6D-4C37-B99C-6883F4AD0B95Q34662175-B779B7F4-B562-4E1F-8B85-3EF276D6983EQ34757980-E023DD73-85C8-4C9B-8149-0421CA23161FQ34766579-E471B0E9-416F-431C-A63E-D8F22C2D13A0Q34796058-FC507419-6FEF-47A9-9F88-223F43B8A984Q34797862-D70B201E-DE08-4D44-8536-C6641354A12CQ34824054-2E89550D-FF30-4EAD-ADEF-82B83D1D964EQ34909956-EFD4D735-F979-41D3-B61D-0A6A94136EE1Q34973743-F86397F8-6ACE-40F4-992C-5EA03E4532B2Q34988793-B365C7C1-56C9-4CA1-9083-23F05FDCEE1AQ35027522-3BDF3F6C-826F-4296-B2A2-0CC0F43A99A1Q35103889-434BC847-0C7B-4F4D-AAE4-B55892B3C64BQ35346991-D18C5FEB-60F9-49DC-887F-B627E564F420Q35522994-91FEDDE6-3225-44FC-920A-7C25497F7A63Q35540652-4D2D0F8A-AAB1-4E6C-A87E-CE168115D142Q35577903-273DED4D-9A68-4C62-9DAE-5B265224F0F9Q35581099-93A1E258-4A68-4814-8986-82708F1C961BQ35696092-EEEDBB89-C7F1-486A-A8E3-BA2B17BD0B93Q35755942-E6940262-455F-4F60-916D-6BD7DB5DD716
P2860
CCR3 is a target for age-related macular degeneration diagnosis and therapy
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
CCR3 is a target for age-related macular degeneration diagnosis and therapy
@ast
CCR3 is a target for age-related macular degeneration diagnosis and therapy
@en
CCR3 is a target for age-related macular degeneration diagnosis and therapy
@en-gb
CCR3 is a target for age-related macular degeneration diagnosis and therapy
@nl
type
label
CCR3 is a target for age-related macular degeneration diagnosis and therapy
@ast
CCR3 is a target for age-related macular degeneration diagnosis and therapy
@en
CCR3 is a target for age-related macular degeneration diagnosis and therapy
@en-gb
CCR3 is a target for age-related macular degeneration diagnosis and therapy
@nl
prefLabel
CCR3 is a target for age-related macular degeneration diagnosis and therapy
@ast
CCR3 is a target for age-related macular degeneration diagnosis and therapy
@en
CCR3 is a target for age-related macular degeneration diagnosis and therapy
@en-gb
CCR3 is a target for age-related macular degeneration diagnosis and therapy
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
CCR3 is a target for age-related macular degeneration diagnosis and therapy
@en
P2093
Alison A Humbles
Ariel Munitz
Atsunobu Takeda
Balamurali K Ambati
Brian J Raisler
Craig J Gerard
Hiroki Kaneko
Jayakrishna Ambati
John D Wright
Judit Z Baffi
P2860
P2888
P304
P3181
P356
10.1038/NATURE08151
P407
P577
2009-06-14T00:00:00Z
P5875
P6179
1053680142